A pre-inspection evidence pack for FDA, COFEPRIS and ANVISA — zero documentary reconstruction
iLEAN Edge + Agents automatically generates an auditable dossier of every critical change and every deviation: pre/post photos, a decision log and timestamped electronic signatures, organized by standard (FDA cGMP, COFEPRIS GMP, ANVISA, ICH). The auditor downloads the period's evidence pack from the web without the plant reconstructing anything. It is the direct lever to drive the historical deviations curve towards zero.
Two weeks reconstructing evidence is not inspection preparation, it is a gamble.
FDA, COFEPRIS and ANVISA audits demand structured evidence: for every critical change and every deviation it must be demonstrable, event by event, what was done, who decided it, who signed it and when. Today, in a hormonal pharma plant, that means:
- 2 weeks of manual pre-inspection reconstruction — the Quality team tracing photos, closing pending signatures and ordering annexes, with the nonconformity risk from documentary gaps that only surface once the inspector is already in the plant.
- Inconsistencies between the electronic batch record and the paper annexes — the deviation is in the system but the photo is on a phone, the checklist in a folder and the signature on another sheet: when the inspector points at a specific batch, everything must be cross-referenced by hand hoping it adds up.
It is the ground where Quality wins or loses year after year: the historical deviations curve and its documentation decide how every inspection ends.
Agents does not generate the evidence from scratch — it organizes what Edge and Connect already captured.
This case depends on the critical change and the deviation being captured the moment they happen: that is what iLEAN Edge does (pre/post photos and data for every change at the critical points) and iLEAN Connect (a decision log, electronic signatures). The Agents piece comes afterwards: it collects that already-captured evidence, organizes it by certifying standard and generates the structured dossier by period or by batch. Zero post-hoc human work. Without Edge and Connect capturing in the plant there is nothing to organize — Agents does not invent what was not captured.
Every critical change and every deviation triggers the capture. Agents organizes by standard. The auditor logs into the web and downloads the dossier.
How Agents operates on the evidence already captured in hormonal pharma:
- Capture at the source (Edge + Connect) — every critical change and every deviation automatically triggers: pre/post photos + a decision log + timestamped electronic signatures. 21 CFR Part 11 by design: every signature carries user, timestamp and hash. Agents does not generate this; it collects what Edge and Connect already captured in the moment.
- Organization by certifying standard — Agents maintains a dossier template for every standard applying to the plant: FDA cGMP, COFEPRIS GMP, ANVISA, the ICH guidelines. The same body of evidence is reorganized by period or by batch per the corresponding template, without capturing anything twice. Compatible with the compliance contract's audit trail and change control pillars.
- The auditor's portal — the inspector enters with a temporary read-only access the plant grants, picks the period and the standard, and downloads the pre-assembled pack. Nobody in Quality has to sit down to cross the electronic batch record with the paper annexes.
A reconstruction sprint vs. a dossier already organized by standard
| Aspect | Manual reconstruction | With iLEAN Edge + Agents |
|---|---|---|
| Pre-audit reconstruction | 2 weeks of the Quality team | Zero — the pack already exists |
| The documentary nonconformity risk | Gaps surfacing with the inspector in the plant | Eliminated — gaps visible before the inspection, not during it |
| The electronic batch record vs. the paper annexes | Cross-referenced by hand per batch, with inconsistencies | A single piece of evidence per event, already crossed with the batch |
| Organization by standard | A separate dossier built from scratch per agency | Agents organizes the same data for FDA cGMP, COFEPRIS GMP, ANVISA and ICH |
| Signatures and traceability | Pending signatures chased the week before | An electronic signature with user, timestamp and hash in the moment (21 CFR Part 11) |
| The auditor's access | Quality presents folders in person | A dedicated portal — pick period and standard, download |
Impact estimate for your plant — to be validated with your own numbers.
The block below is an estimate to be validated against your plant's actual data. We put it forward so the committee has an order of magnitude; we refine it during the assessment.
- Hormonal pharma plant with an active regulatory qualification before FDA and/or COFEPRIS, and an exporting segment — typically the US market — tied to that qualification.
- Edge + Agents pilot on one line's critical changes and deviations. First complete evidence pack expected within a few weeks of deployment.
- Estimated payback between 6 and 12 months, depending on inspection frequency and the exporting segment's value. Estimate to be validated.
- The hard lever is the continuous protection of the regulatory qualification: in plants with the US export market we usually talk about more than €1M a year tied to that qualification. Estimate to be validated with your data.
And the fair question from the Quality lead
"What if the pack looks complete but something is missing?" — Agents' work is an anchored task, not free generation: it organizes real evidence captured by Edge and Connect by period, batch and standard, it does not fill gaps with invented content. In anchored tasks, the best models brought the error below 1.5% [1]. And if an event is missing, the pack shows it as a gap, it does not camouflage it — the Quality person reviews the dossier before handing the credential to the inspector.
[1] OpenAI paper "Why Language Models Hallucinate", 2025 — on the reliability of AI in anchored tasks.
What people ask about the pre-inspection evidence pack in hormonal pharma
What happens if an event was not captured automatically at the time?
If a critical change or a deviation was not captured by Edge or Connect when it happened (a device offline, an unrecorded round, a photo not taken), the pack for that period explicitly shows the gap — it neither fills it nor hides it. iLEAN Agents does not generate evidence: it organizes what Edge and Connect already captured and flags, just as clearly, where something is missing. In an FDA or COFEPRIS inspection, a visible gap explained by Quality before the visit is manageable; a dossier that looks complete without being so is exactly what triggers a serious observation.
How is it organized for several standards at once (FDA cGMP, COFEPRIS GMP, ANVISA, ICH)?
The base evidence is the same — pre/post photos, a decision log, timestamped electronic signatures — but each certifier asks for the dossier with a different structure and emphasis. Agents maintains an output template per standard: FDA cGMP (21 CFR 210/211), COFEPRIS NOM-059 (GMP), ANVISA RDC and the applicable ICH Q7/Q10 guidelines. The same body of evidence is reorganized according to the template the user picks in the portal, by period or by batch. Nothing has to be captured twice and no parallel dossiers per agency have to be maintained.
Who has access to the auditor's portal?
Access is granted by the plant, not iLEAN. The Quality lead generates a temporary credential — scoped to the period, the standard and, if applicable, the batch of that specific inspection — and hands it to the inspector or external auditor. They log in, pick period and standard, and download the evidence pack; they see nothing outside that scope and cannot modify any record: access is read-only and is itself logged in the audit trail.
How much does it really save versus manual pre-inspection reconstruction?
In a hormonal pharma plant with an export market, preparing an FDA or COFEPRIS inspection usually occupies the Quality team for about two weeks: tracing photos and paper annexes, crossing them with the electronic batch record, closing pending signatures. With the dossier generated automatically for every critical change and every deviation, that post-hoc work disappears: the pack already exists before the inspection is announced. The direct saving is those Quality hours; the big saving is the avoided documentary nonconformity risk over the regulatory qualification. Concrete figures, an estimate to be validated with your plant's data.
Can it generate the pack for periods before the deployment?
No. Agents only organizes evidence that exists. For periods before the Edge/Connect deployment there are no pre/post photos or structured logs to organize, so the automatic pack cannot be generated retroactively — for that history, the plant keeps relying on whatever documentation it already had on file. What changes from day one is that every critical change and every deviation going forward is captured with signature and timestamp, so each future inspection covers an ever-larger window of already-secured period.
The auditor logs into the web and downloads the dossier — tell us your case and we will send within 48h the estimated ROI for your hormonal pharma plant.
We work on your plant's real data, not ours. Assessment with no commitment.
Request estimated ROI within 48h ‹ See all 13 hormonal pharma cases See pharma